Opko Health OPK Pharmaceutical — Cost of Goods Sold

Other segment segments

Similar metrics at other companies

LQD

LQDAProduct — Cost of Goods Sold

$11.08M—

BAXPharmaceuticals — Cost of Sales

$458M+15.7%

ETONProduct Sales And Royalties — Cost of Goods Sold

$9.53M+44.5%

NTNXProduct — Cost of Goods Sold

$5.82M-14.2%

WOOFProduct — Cost of Goods Sold

$757.78M-1.1%

ATRPharma — Cost of Sales (exclusive of depreciation and amortization):

$228.54M+11.4%

Questions, answered.

What is Opko Health's pharmaceutical — cost of goods sold?

Opko Health (OPK) reported pharmaceutical — cost of goods sold of $22.3M in Q1 2026.

How has Opko Health's pharmaceutical — cost of goods sold changed year-over-year?

Opko Health's pharmaceutical — cost of goods sold decreased by 2.3% year-over-year, from $22.81M to $22.3M.

What is the long-term trend for Opko Health's pharmaceutical — cost of goods sold?

Over 2 years (2023 to 2025), Opko Health's pharmaceutical — cost of goods sold has grown at a -3.0% compound annual growth rate (CAGR), from $99.54M to $93.59M.

What does pharmaceutical — cost of goods sold mean?

The direct costs attributable to the production and delivery of pharmaceutical products and services. This includes raw materials, manufacturing labor, and overhead costs directly associated with generating pharmaceutical revenue.